Prescription drug · UNAPPROVED DRUG OTHER
Sodium Sulfacetamide 8% and Sulfur 4% (Sulfacetamide sodium, sulfur) NDC 71399-0487
Sulfacetamide sodium 80 mg/mL; Sulfur 40 mg/mL · Suspension · Topical · Akron Pharma Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71399-0487-6 | 7139904870671399048706 | 473 mL in 1 BOTTLE, PLASTIC (71399-0487-6)Marketed from Sep 13, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium Sulfacetamide 8% and Sulfur 4%
- Generic name (nonproprietary)
- sulfacetamide sodium, sulfur
- Active ingredients
- Sulfacetamide sodium — 80 mg/mLSulfur — 40 mg/mL
- Dosage form
- Suspension
- Route
- Topical
- Labeler
- Akron Pharma Inc.NDC labeler code 71399
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonamides (Chemical structure)
- Identifiers
- Product ID 71399-0487_a4bb29b0-065f-428b-9d9b-bb4e564449d3SPL ID a4bb29b0-065f-428b-9d9b-bb4e564449d3SPL set ID bfbe625c-5679-4363-913a-2ab03198f4f0RxCUI 1010234UNII 4NRT660KJQ, 70FD1KFU70
- Pharmacologic class
- Sulfonamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471399048706followed by a unit qualifier and the quantityPackage 71399-0487-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Excerpt only. Read the full label for complete information.
About NDC 71399-0487
- What is NDC 71399-0487?
- 71399-0487 is the product NDC for Sodium Sulfacetamide 8% and Sulfur 4%, Sulfacetamide sodium 80 mg/mL; Sulfur 40 mg/mL suspension, listed with the FDA by Akron Pharma Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sodium Sulfacetamide 8% and Sulfur 4% (Sulfacetamide sodium, Sulfur).
- What is the active ingredient?
- Sulfacetamide sodium, Sulfur.
- Who is the labeler?
- Akron Pharma Inc., NDC labeler code 71399. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sodium Sulfacetamide 8% and Sulfur 4%?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.